Committing to its roots, SAGEbio is now also incorporated in the Kingdom. Transfer of Saudi-developed technologies to the KAUST-based biotech start-up SAGEbio, which will take over responsibilities and operations from first in-human administration onwards will enable a rapid development to market strategy.

SAGEbio is now open for business after incorporation as an LLC in the United States. The company secured a presence right in the heart of the world’s most prolific biotechnology and health tech hub. The office located in the CIC building in Cambridge, Massachusetts is in walking distance to Boston’s the world leading universities and hospitals.